BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 18670305)

  • 1. Gaps in optimal care for lung cancer.
    Vinod SK; O'Connell DL; Simonella L; Delaney GP; Boyer M; Peters M; Miller D; Supramaniam R; McCawley L; Armstrong B
    J Thorac Oncol; 2008 Aug; 3(8):871-9. PubMed ID: 18670305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
    Richardson GE; Thursfield VJ; Giles GG
    Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current treatment concepts of lung cancer].
    Kaiser F; Engelhardt M; Rawluk J; Mertelsmann R; Passlick B; Wäsch R
    Dtsch Med Wochenschr; 2011 Sep; 136(38):1901-6. PubMed ID: 21915805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer in New Zealand: patterns of secondary care and implications for survival.
    Stevens W; Stevens G; Kolbe J; Cox B
    J Thorac Oncol; 2007 Jun; 2(6):481-93. PubMed ID: 17545842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distance from accessible specialist care and other determinants of advanced or unknown stage at diagnosis of people with non-small cell lung cancer: A data linkage study.
    Tracey E; McCaughan B; Badgery-Parker T; Young J; Armstrong B
    Lung Cancer; 2015 Oct; 90(1):15-21. PubMed ID: 26275475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recommendations on the therapy of bronchial carcinoma].
    Thomas M; Baumann M; Deppermann M; Freitag L; Gatzemeier U; Huber R; Passlick B; Serke M; Ukena D
    Pneumologie; 2002 Feb; 56(2):113-31. PubMed ID: 11842350
    [No Abstract]   [Full Text] [Related]  

  • 7. Why do some lung cancer patients receive no anticancer treatment?
    Vinod SK; Sidhom MA; Gabriel GS; Lee MT; Delaney GP
    J Thorac Oncol; 2010 Jul; 5(7):1025-32. PubMed ID: 20453689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bronchial cancer--development, diagnosis, therapy, prognosis].
    Zöchbauer S; Krajnik G; Huber H
    Wien Klin Wochenschr; 1994; 106(14):431-47. PubMed ID: 7941590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The trajectory of lung cancer patients in Western Australia--a data linkage study: still a grim tale.
    Jiwa M; Maujean E; Spilsbury K; Threlfal T
    Lung Cancer; 2010 Oct; 70(1):22-7. PubMed ID: 20129694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment disparities for disabled medicare beneficiaries with stage I non-small cell lung cancer.
    Iezzoni LI; Ngo LH; Li D; Roetzheim RG; Drews RE; McCarthy EP
    Arch Phys Med Rehabil; 2008 Apr; 89(4):595-601. PubMed ID: 18373987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do multidisciplinary team meetings make a difference in the management of lung cancer?
    Boxer MM; Vinod SK; Shafiq J; Duggan KJ
    Cancer; 2011 Nov; 117(22):5112-20. PubMed ID: 21523766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of conformal radiotherapy technique on survival after chemoradiotherapy for patients with stage III non-small cell lung cancer in the National Cancer Data Base.
    Sher DJ; Koshy M; Liptay MJ; Fidler MJ
    Cancer; 2014 Jul; 120(13):2060-8. PubMed ID: 24692108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the Netherlands.
    Wouters MW; Siesling S; Jansen-Landheer ML; Elferink MA; Belderbos J; Coebergh JW; Schramel FM
    Eur J Surg Oncol; 2010 Sep; 36 Suppl 1():S83-92. PubMed ID: 20598845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-Dimensional Radiation Therapy to the Primary Tumor With Concurrent Chemotherapy in Patients With Stage IV Non-Small Cell Lung Cancer: Results of a Multicenter Phase 2 Study From PPRA-RTOG, China.
    Su S; Li T; Lu B; Wang X; Li J; Chen M; Lu Y; Bai Y; Hu Y; Ouyang W; Ma Z; Li Q; Li H; Wang Y
    Int J Radiat Oncol Biol Phys; 2015 Nov; 93(4):769-77. PubMed ID: 26530745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
    Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
    J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival of chemo-radiotherapy-treated and thermotherapy-treated patients with unresectable lung cancer.
    Rizzo S
    Oncol Rep; 1998; 5(3):667-71. PubMed ID: 9538173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of demographic characteristics, surgical resection patterns, and survival outcomes for veterans and nonveterans with non-small cell lung cancer in the Pacific Northwest.
    Zeliadt SB; Sekaran NK; Hu EY; Slatore CC; Au DH; Backhus L; Wu DY; Crawford J; Lyman GH; Dale DC
    J Thorac Oncol; 2011 Oct; 6(10):1726-32. PubMed ID: 21857253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of tumor size on prognosis in patients treated with radical radiotherapy or chemoradiotherapy for non-small cell lung cancer. An analysis of the staging project database of the International Association for the Study of Lung Cancer.
    Ball D; Mitchell A; Giroux D; Rami-Porta R;
    J Thorac Oncol; 2013 Mar; 8(3):315-21. PubMed ID: 23334092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lung cancer treatment present and future.
    Cho JK
    Hawaii Med J; 2003 Mar; 62(3):61-2. PubMed ID: 12703177
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment and prognosis of advanced stage non-small-cell lung cancer].
    Chermiti Ben Abdallah F; Ben Ali G; Sadok Boudaya M; Mlika M; Chtourou A; Taktak S; Ben Kheder A
    Rev Mal Respir; 2014 Mar; 31(3):214-20. PubMed ID: 24680112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.